Kristen Bell is one of the many celebrities who have written a children's book
Kristen Bell is one of the many celebrities who have written a children's book
Facebook's data tool now lets you transfer notes and posts to Google Docs, Blogger and Wordpress.
The share of school districts continuing to offer virtual-only instruction to students fell below 10 percent for the first time since the coronavirus pandemic began, according to statistics on pandemic schooling compiled weekly by the data firm Bubio.
A Swiss company whose market capitalization rose at one time to more than 1.5 billion Swiss francs ($1.6 billion) on hopes an old drug it owned would succeed against COVID-19 is embroiled in a dispute with U.S. partner NeuroRx, it said in a statement. Relief Therapeutics' market cap has fallen about 70% from a high in the third quarter of 2020, as the company's aviptadil, a 50-year-old medicine, failed to win U.S. emergency approval and in February demonstrated no survival benefit at 28 days in a U.S. clinical trial of people with COVID-19 respiratory failure. Relief said on Monday that NeuroRx and it are fighting over issues including sharing of trial data, invoices totaling about $4 million that NeuroRx contends Relief must pay, funding for clinical trials, the allocation of potential profits, and other issues.
Mastercard Inc said on Monday it had agreed to buy digital identity verification company Ekata in a deal valued at $850 million, as the global payment processor bets on a boom in demand for companies in the digital security space. "The acceleration of online transactions has thrust global digital identity verification to the forefront as one of the biggest opportunities to build digital trust and combat global fraud," said Rob Eleveld, chief executive officer of Ekata, in a statement. Seattle-headquartered Ekata counts more than 2,000 companies as its partners, including credit reporting company Equifax Inc and software firm Intuit Inc, its website showed.
The "Investigation Report on China's Hydroxychloroquine Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Awards Recognize Marketing Organizations Who Empower the Success of Their Channel Partners and Drive Local Revenue GrowthCHICAGO, April 19, 2021 (GLOBE NEWSWIRE) -- BrandMuscle, the industry leader in integrated local and channel marketing, is proud to announce the winners of the company’s first annual Channel Marketing Excellence Awards. The BrandMuscle Channel Marketing Excellence Awards recognize marketing organizations who achieve exceptional success in programs that empower their channel partners to drive local revenue growth. “While national advertising is important, nearly 75% of all purchases occur through a local channel,” said Mike Marchetti, Chief Customer Officer at BrandMuscle. “The Channel Marketing Excellence Awards showcase the revenue impact and return on investment that is achievable when national and local marketing strategies are aligned and optimized across the entire buyer’s journey. The winners of this year’s awards have done an incredible job activating local marketing programs and campaigns that drove impactful business results for their channel partners and businesses.” Twenty-four entries were submitted from eighteen unique companies for consideration in six different awards categories. Each nominee exemplified strong commitment to its channel partners and leveraged best practices for local marketing as recommended in The State of Local Marketing Report. This year’s categories, winners, and finalists are: State of Local Marketing Maturity Achievement Winner – GE AppliancesFinalists – Ace Hardware, Goodyear Tire and Rubber Company SpotMenus Promoter of the Year Winner – FedwayFinalists – Republic National Distributing Company, Southern Glazer’s Wine and Spirits Most Improved Channel Marketing Program Performance Winner – American Family Mutual Insurance CompanyFinalists – Ace Hardware, Farmers Insurance Group, UScellular Best Channel Partner Support During COVID-19 Winner – UScellularFinalists – Bobcat Company, American Family Mutual Insurance Company Channel Partner Champion of the Year Winner – Bobcat CompanyFinalists – Pandora, American Family Mutual Insurance Company Best Channel Support for Launching a New Product or Campaign Winner – Nationwide Mutual Insurance CompanyFinalists – Align Technology, Campari, Four Roses Nominations were evaluated by a panel of five judges comprised of independent and BrandMuscle channel marketing experts: Bill Dinan, President of Localogy; Rob Hand, CEO of Hand Promotion Management; Mike Kaufman, Vice President of Brand Activation at the Association of National Advertisers; Mike Marchetti, Chief Customer Officer at BrandMuscle; and Sarah Cucchiara, Senior Vice President of Channel Marketing Strategy at BrandMuscle. The judges were consistently impressed by all the finalists’ commitment to educating and distributing resources to channel partners, as well as how quickly and efficiently many of them pivoted their messaging and offerings in response to COVID-19. “Congratulations to all the winners and nominees of this year’s Channel Marketing Excellence Awards,” said Marchetti. “We’re proud to support your channel marketing initiatives with best-in-class services and solutions and look forward to seeing your strategies and brands continue to grow.” For more information about the Channel Marketing Excellence Awards visit: https://www.brandmuscle.com/resources/channel-marketing-excellence-awards-2021/ About BrandMuscleBrandMuscle is the leader in integrated local and channel marketing, serving over 300 of the world’s top brands, with 700 professionals in seven offices globally. The BrandMuscle Intelligent Local Marketing Platform enables brands and their local marketing partners to deliver the greatest marketing impact to each individual customer. BrandMuscle simplifies and scales digital and physical marketing execution, enabling brands to acquire and retain the best customers, build loyalty, enhance lifetime customer value, and maximize ROI. For more information about BrandMuscle visit https://www.brandmuscle.com/ or call (866) 464-4342. CONTACT: Contact: Lori Alba VP of Marketing email@example.com 216-454-2047
SPM Communications, an award-winning public relations, crisis management and social media marketing agency, continues to grow its client roster — and its team — with six new business wins in the CPG and restaurant categories.
Artificial Intelligence In Medical Diagnostics Market Research Report by Technology (Computed Tomography, Magnetic Resonance Imaging, Neuroradiology, and Radiology), by Application (Data Mining, Data Storage, Follow-up Plan, Image Acquisition, and Processing to Aided Reporting) - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, April 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Artificial Intelligence In Medical Diagnostics Market Research Report by Technology, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06063085/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Artificial Intelligence In Medical Diagnostics Market is expected to grow from USD 683.66 Million in 2020 to USD 1,414.56 Million by the end of 2025.2. The Global Artificial Intelligence In Medical Diagnostics Market is expected to grow from EUR 599.45 Million in 2020 to EUR 1,240.31 Million by the end of 2025.3. The Global Artificial Intelligence In Medical Diagnostics Market is expected to grow from GBP 532.91 Million in 2020 to GBP 1,102.64 Million by the end of 2025.4. The Global Artificial Intelligence In Medical Diagnostics Market is expected to grow from JPY 72,964.67 Million in 2020 to JPY 150,969.39 Million by the end of 2025.5. The Global Artificial Intelligence In Medical Diagnostics Market is expected to grow from AUD 992.77 Million in 2020 to AUD 2,054.12 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Artificial Intelligence In Medical Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Technology, the Artificial Intelligence In Medical Diagnostics Market studied across Computed Tomography, Magnetic Resonance Imaging, Neuroradiology, and Radiology. Based on Application, the Artificial Intelligence In Medical Diagnostics Market studied across Data Mining, Data Storage, Follow-up Plan, Image Acquisition, and Processing to Aided Reporting. Based on Geography, the Artificial Intelligence In Medical Diagnostics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence In Medical Diagnostics Market including Aidoc Medical Ltd., Arterys Inc., Butterfly Network Inc., Caption Health, Inc., Enlitic, Inc., Freenome Holdings, Inc., Gauss Surgical Inc., GE Healthcare Inc., General Vision, Inc., Google Inc., Health Fidelity, Inc., IBM Corporation, IBM Corporation, IDx Technologies Inc., Imagen Technologies, Inc., Intel Corporation, Johnson & Johnson Services, Inc., MaxQ AI, Ltd, Medtronic PLC, Microsoft Corporation, Qure.ai, Riverain Technologies, Riverain Technologies, Siemens Healthineers AG, SigTuple Technologies Private Limited, VUNO Inc, and Zebra Medical Vision Ltd. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence In Medical Diagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Artificial Intelligence In Medical Diagnostics Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence In Medical Diagnostics Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence In Medical Diagnostics Market?4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence In Medical Diagnostics Market?5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence In Medical Diagnostics Market?6. What are the modes and strategic moves considered suitable for entering the Global Artificial Intelligence In Medical Diagnostics Market?Read the full report: https://www.reportlinker.com/p06063085/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - International Lithium Corp. (TSXV: ILC) (the "Company" or "ILC") is pleased to announce that the Company has completed a maiden diamond drilling program on the Raleigh Lake Lithium project near Ignace, Ontario, Canada. A total of 1,504 metres of NQ core drilling were completed in eight holes to test the continuity of spodumene bearing pegmatites and their associated lithium, tantalum and cesium mineralization down dip ...
Led by Tiger Global, the financing values Virta at $2B and signals a shift in type 2 diabetes care toward long-term disease reversal.
(Bloomberg) -- Peloton Interactive Inc. shares fell nearly 8% Monday after U.S. regulators warned consumers to stop using the exercise equipment maker’s Tread+ machine if there are young children or pets at home.The advisory follows a series of accidents involving the treadmill and the U.S. Consumer Product Safety Commission (CPSC) said Saturday it is continuing to investigate incidents of injury or death related to the Tread+.Peloton said in a statement that it was “concerned” by the commission’s warning, which it termed “misleading and inaccurate.” There’s no reason to stop using the Tread+ as long as all warnings and safety instructions are followed, it said.JPMorgan Chase & Co. analyst Doug Anmuth reiterated his overweight rating on the stock and recommended buying during any pullback in the shares related to the CPSC’s warning.“Peloton emphasizes that the Tread+ is safe when its warnings and safety instructions are followed, and the company will neither stop selling nor recall the Tread+,” Anmuth said in a research note. He doesn’t expect the recent incidents or the CPSC’s warning to further delay Peloton’s launch of its new lower-priced Tread in the U.S., he added.The stock hit a low of $108.62 at the open, briging its decline so far this year to 25.8%.READ MORE: U.S. Regulators Warn Consumers About Peloton’s Tread+ (1)(Updates share price move in the first paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Gigantor Technologies Inc. is set to disrupt the market with its multiple patent-pending revolutionary technology, GigaMACS. Co-founders Don Gaspar, CEO, and Mark Mathews, CTO, formed Gigantor after analyzing the market’s existing approach to acceleration using stock hardware solutions or imprecise model altering strategies.
The "Animal Biotechnology - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
How long will it take to reach a verdict? Judge Peter Cahill has told jurors to "pack a bag" and "plan for long (deliberations) and hope for short."
The lowest case rates in Charlotte are in ZIP codes 28207 and 28210, near SouthPark and along Park Road.
It goes without saying, but the last 12 months have had an undeniable impact on the wedding world. The big, bold designer gowns meant for lavish celebrations remained on their hangers as women selected casual, streamlined pieces for their backyard or virtual events. A Bridal Fashion Week—which debuted designers' Spring/Summer 2022 collections—unlike any other.
American singer Andra Day says portraying legendary blues performer Billie Holiday has made her braver. The 36-year-old has been nominated for a best actress Oscar for her debut role in "The United States vs. Billie Holiday", which looks at the jazz singer's part in the push for Black civil rights and the outcry caused by her singing the ballad "Strange Fruit". Holiday initially performed the protest song about the lynching of Black people in 1939 at New York City’s first racially integrated nightclub, Cafe Society.
Financing for the breakaway club competition is 'one of the biggest ever' deals, according to experts.
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Herman Miller, Inc. (NASDAQ: MLHR) and Knoll, Inc. is fair to Herman Miller shareholders. Under the terms of the merger, Knoll shareholders are expected to receive a combination of cash and Herman Miller stock. Upon completion of the transaction, Herman Miller shareholders will own approximately 78% of the combined company.